product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Quantikine Immunoassay Control for Human VE-Cadherin
catalog :
QC184
quantity :
1 Each
price :
175 USD
more info or order :
product information
brand :
R&D Systems
master code :
QC184
SKU :
QC184
product name :
Quantikine Immunoassay Control for Human VE-Cadherin
sizes available :
1 Each
description :
The Quantikine Immunoassay Control Set1076 for Human VE-Cadherin from QC184 quantifies human .
target :
VE-Cadherin
category :
ELISAs
dilution :
ELISA, Control
species :
Human
gene symbol :
CDH5
url print :
?utm_source=biocompare&utm_medium=referral&utm_campaign=product&utm_term=elisas
applications :
ELISA, Control
extended description :
For use with catalog number DCADV0
USD :
175 USD
product details :
For use with catalog number DCADV0
alt names :
7B4, 7B4 antigen, cadherin 5, type 2 (vascular endothelium), cadherin 5, type 2, VE-cadherin (vascular epithelium), cadherin-5, CD144, CD144 antigen, CDH5, endothelial-specific cadherin, FLJ17376, Vascular endothelial cadherin, VE-cadherin, VECadherin
storage :
Store the unopened product at 2 - 8 °C. Do not use past expiration date.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
- Quantikine Immunoassay Control for Human Fetuin A | QC90
- Quantikine Immunoassay Control for Human C1qR1/CD93 | QC55
- Quantikine Immunoassay Control for Human CX3CL1/Fractalkine | QC93
- Quantikine Immunoassay Control for Human Galectin-3BP/MAC-2BP | QC95
- Quantikine Immunoassay Control Set 896 HIV-1 Gag p24 | QC221
questions and comments
